Report Metrics Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $218.

The additional recruitments will help the Drugs Controller General of India enforce good manufacturing practices for ...

More than 1 in 5 Americans likely suffer from long COVID, a new AI-assisted review has found. The analysis suggests that ...

17,21,22 Tezspire is approved in the US, the EU and nearly 60 countries for the add-on maintenance treatment of adult and ...

I was the only one in my class of 30 who had the ailment; today, one in three children has it. Perhaps I did not own or care for my city enough to do justice to my privilege, education and lived ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

Cooper Vision describes keratoconus as 'a condition where the cornea protrudes outward like a cone'.

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

According to the site, 'Inflammation from things like allergies, asthma, or atopic eye disease can break down the tissue of ...